Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Exploring the Influence of Health Insurance Plans on Biosimilar Adoption Rates ; volume:8 ; number:1 ; day:3 ; month:11 ; year:2023 ; pages:115-118 ; date:1.2024
PharmacoEconomics - open ; 8, Heft 1 (3.11.2023), 115-118, 1.2024
- Urheber
-
Costin, Jeremy
Mouslim, Morgane C.
Socal, Mariana P.
Trujillo, Antonio
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s41669-023-00447-6
- URN
-
urn:nbn:de:101:1-2024032510225159046536
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Costin, Jeremy
- Mouslim, Morgane C.
- Socal, Mariana P.
- Trujillo, Antonio
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Internet financial reporting adoption: Exploring the influence of board role performance and isomorphic forces
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Assessing peer influence on farmers’ climate adaptations: An experimental adoption of index insurance and savings in Uzbekistan
Assessing peer influence on farmers’ climate adaptations : An experimental adoption of index insurance and savings in Uzbekistan
MYL-1402O: A Bevacizumab Biosimilar
Exploring organizational adoption of cloud computing in Singapore
Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Internet financial reporting adoption: Exploring the influence of board role performance and isomorphic forces
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Assessing peer influence on farmers’ climate adaptations: An experimental adoption of index insurance and savings in Uzbekistan
Assessing peer influence on farmers’ climate adaptations : An experimental adoption of index insurance and savings in Uzbekistan
MYL-1402O: A Bevacizumab Biosimilar
Exploring organizational adoption of cloud computing in Singapore
Introducing the Biosimilar Paradigm to Neurology: The Totality of Evidence for the First Biosimilar Natalizumab
Impact of Value-Driven Healthcare Strategies for Biosimilar Adoption: The Singapore Story
European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption
Internet financial reporting adoption: Exploring the influence of board role performance and isomorphic forces
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
AVT02: An Adalimumab Biosimilar
SB8: A Bevacizumab Biosimilar
AVT04: An Ustekinumab Biosimilar
Assessing peer influence on farmers’ climate adaptations: An experimental adoption of index insurance and savings in Uzbekistan
Assessing peer influence on farmers’ climate adaptations : An experimental adoption of index insurance and savings in Uzbekistan
MYL-1402O: A Bevacizumab Biosimilar
Exploring organizational adoption of cloud computing in Singapore